Abstract
Proposals unlikely to remove the cloud surrounding first-in-human trials of many novel biologics
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Related links
Related links
Related links in Nature Research
Fresh light thrown on tragic drug trial
New test could weed out dangerous drug trials
Missing results might have rung warning bell over trial drug
Verdict confirms fate of 'elephant man' drug volunteers
Web links
European Medicines Evaluation Agency
Rights and permissions
About this article
Cite this article
Mitchell, P. Critics pan timid European response to TeGenero disaster. Nat Biotechnol 25, 485–486 (2007). https://doi.org/10.1038/nbt0507-485
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0507-485
This article is cited by
-
Erratum: Critics pan timid European response to TeGenero disaster
Nature Biotechnology (2007)
